Tocilizumab in COVID-19: some clarity amid controversy
Shruti Gupta, David E. Leaf
Topics & Concepts
Coronavirus disease 2019 (COVID-19)TocilizumabCLARITY2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyMedicineImmunologyInternal medicineBiologyInfectious disease (medical specialty)DiseaseRheumatoid arthritisOutbreakBiochemistryCOVID-19 Clinical Research StudiesInflammasome and immune disordersLong-Term Effects of COVID-19